Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Medicinova (MNOV) Gross Margin (2025)

Medicinova (MNOV) has disclosed Gross Margin for 2 consecutive years, with 3.13% as the latest value for Q4 2025.

  • On a quarterly basis, Gross Margin changed N/A to 3.13% in Q4 2025 year-over-year; TTM through Dec 2025 was 1369.62%, a N/A change, with the full-year FY2025 number at 7.58%, changed N/A from a year prior.
  • Gross Margin was 3.13% for Q4 2025 at Medicinova, up from 489557.98% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 3.13% in Q4 2025 to a low of 3.13% in Q4 2025.